title: RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells.
abstract: Retinoic acid (RA) is a signaling molecule that plays a pivotal role in major cellular processes and vertebrate development. RA action is mediated by specialized transcription factors, the nuclear RA receptors (RARs), which regulate the transcription of genes containing a RA-responsive element (RARE). Here we demonstrate that the genes for the RA-receptor RARbeta2 and the cytochrome P450 RA-specific hydrolase Cyp26a1 involved in RA catabolism are coordinately regulated by RA. We found that both RARbeta2 and Cyp26a1 genes are epigenetically silenced in the absence of DNA methylation in RAC65, a P19 embryocarcinoma cell line derivative carrying a dominant-negative RARalpha mutant and resistant to the growth-inhibitory and differentiation effects of RA. In response to RA, RARbeta2 transcription is epigenetically regulated by RARalpha. Similarly, we found that Cyp26a1 transcription is epigenetically regulated by RARbeta2. Knocking down RARbeta2 transcription by RNA interference in wild-type P19 cells, with an intact RARalpha, induced Cyp26a1 transcriptional repression in the absence of DNA methylation. Concomitantly, cells developed RA resistance and did not undergo RA-induced neuron differentiation. Apparently, RARalpha, RARbeta2 and Cyp26a1 are components of a RA-regulated gene network. Factors affecting an upstream gene of the network can trigger repressive chromatin changes -- which are propagated in a domino fashion - at downstream genes of the network. This study also shows that chromatin inactivity, and consequent transcriptional silencing, can be achieved in the absence of DNA methylation.
authors.affiliation: Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
authors.forename: S
authors.initials: S
authors.lastname: Pozzi
authors.forename: S
authors.initials: S
authors.lastname: Rossetti
authors.forename: G
authors.initials: G
authors.lastname: Bistulfi
authors.forename: N
authors.initials: N
authors.lastname: Sacchi
mesh_terms: D000818:Animals; D018236:Carcinoma, Embryonal / Q000235:genetics* / Q000473:pathology*; D002454:Cell Differentiation; D002843:Chromatin; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis* / Q000502:physiology; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D020868:Gene Silencing; D051379:Mice; D009474:Neurons; D018168:Receptors, Retinoic Acid / Q000096:biosynthesis* / Q000502:physiology; D000072516:Retinoic Acid 4-Hydroxylase; D014212:Tretinoin / Q000378:metabolism / Q000502:physiology*
chemical_list: D002843:Chromatin; D018168:Receptors, Retinoic Acid; C082925:retinoic acid receptor beta; D014212:Tretinoin; D003577:Cytochrome P-450 Enzyme System; C000607080:Cyp26a1 protein, mouse; D000072516:Retinoic Acid 4-Hydroxylase